Xamic 500 mg/5 ml Injection contains tranexamic acid, an anti-fibrinolytic medicine used to prevent or treat bleeding in various medical and surgical situations. It is given by a healthcare professional.
There are 35 brands of Tranexamic Acid listed in Bangladesh. 14 of them have a lower unit price than Xamic. The lowest listed price is Enclot 250 mg Capsule at ৳ 8.06 per unit.
What is Xamic 500 mg/5 ml Injection?
Xamic 500 mg/5 ml Injection is a medicine that helps control bleeding. It contains tranexamic acid, which belongs to a group called anti-fibrinolytic drugs. These medicines work by slowing down the breakdown of blood clots, so that bleeding is reduced. Xamic is used in several situations where bleeding is a concern, such as certain medical conditions like leukaemia, cirrhosis, and haemophilia, and during surgery. It is available as an injection in a 5 ml ampoule. The dose and how often it is given will be decided by your doctor based on your condition. Always follow your doctor's instructions.
Uses of Xamic
Xamic Injection is used to prevent and treat bleeding in various medical and surgical conditions. It is used in cases such as bleeding from the lungs or digestive tract, bleeding disorders related to leukaemia, cirrhosis, or haemophilia, and low platelet counts. It is also used during surgery to reduce the risk of bleeding, especially in operations on the lungs, heart, and blood vessels. Additionally, it can be used when bleeding occurs as a complication of thrombolytic therapy or blood transfusion. Your doctor will determine if this medicine is appropriate for your specific situation.
How to use Xamic
Xamic Injection is given by a healthcare professional, usually by slow intravenous injection or intramuscular injection. It is not for self-administration. The dose and how often it is given will be decided by your doctor, who will consider your condition, age, weight, and other factors. The injection is given in a hospital or clinic setting where proper monitoring is available. Do not attempt to inject this medicine yourself. Always follow your doctor's instructions and inform them of any other medicines you are taking or any health conditions you have.
Side effects of Xamic
Xamic Injection is generally well tolerated, but some people may experience side effects. These can include fatigue, eye irritation, nasal blockage, itching, skin redness, or rash. After oral administration, nausea, diarrhoea, or heartburn may occur, though this injection is not taken orally. Rarely, a drop in blood pressure upon standing may happen. If you experience any allergic reaction such as swelling, difficulty breathing, or severe rash, seek immediate medical attention. Your doctor will monitor you for any side effects during treatment.
Safety and precautions
Before receiving Xamic Injection, tell your doctor if you are pregnant, planning to become pregnant, or breastfeeding. This medicine is not recommended during pregnancy unless clearly needed. It passes into breast milk in small amounts, but effects on the baby are unlikely. Do not use this medicine if you have a history of blood clots, thrombosis, or serious kidney problems. Caution is advised in less severe kidney disease. Your doctor will assess your condition and may adjust the dose. Always inform your doctor about all medicines you are taking, including oral contraceptives, as interactions can occur. This medicine should only be given by a healthcare professional.
Frequently asked questions
What is Xamic 500 mg/5 ml Injection used for and what kind of medicine is it?
Xamic Injection is used to prevent and treat bleeding in various medical and surgical conditions. It contains tranexamic acid, which is an anti-fibrinolytic medicine. It works by helping to stabilize blood clots and reduce bleeding.
How should Xamic Injection be taken?
Xamic Injection is given by a healthcare professional, usually by slow intravenous or intramuscular injection. The dose and frequency will be decided by your doctor based on your condition. Never self-administer this medicine.
What does the dosage form and strength mean?
Xamic is available as an injection in a 5 ml ampoule, and the strength is 500 mg/5 ml. This means each 5 ml ampoule contains 500 mg of tranexamic acid. It is supplied in packs of 5 ampoules.
In medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.
In surgery: Prophylaxis and antihemorrhagic ... Read moreIn medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.
In surgery: Prophylaxis and antihemorrhagic therapy during operations of any type and nature and particularly in pulmonary, cardiovascular and abdominal surgery and post-operative and traumatic shock.
In urology: Prophylaxis and antihemorrhagic therapy of prostatic, vesical and renal surgery. Hematurias.
In obstetrics: Prophylaxis and therapy of post-partum and puerperium hemorrhages, hemorrhagic metrophathies, functional menometrorrhagias, idiopathic or IUD(lntra uterine Device) induced menorrhagias, primitive hyperfibrinolysis (abruptio placentae, premature placenta detachment) and in cervical conization.
In otorhinolaryngology: Prophylaxis and antihemorrhagic therapy during a tonsillectomy, specialist surgery generally, epistaxis.
In stomatology: Prophylaxis and antihemorrhagic therapy during maxillofacial operations, tooth extractions.
In oncology (as supportive therapy): To promote the formation of a fibrin capsule to wall off and thereby inhibit the growth of ovarian tumors. To cause regression of ascites secondary to carcinoma. To reduce bleeding during surgical interventions.
Pharmacology
This is a preparation of tranexamic acid (trans-4 aminomethyl-cyclohexanecarboxylic acid). Tranexamic acid is a substance endowed with a strong antifibrinolytic action and both in vivo and in vitro it has proved to be 10 times more active than conventional hemostatics, depending on the test. The antihemorrhagic action of tranexamic acid is essentially due to an inhibition of the plasminogen activation of both exogenous activators like streptokinase and endogenous ones like urokinase and the plasminogen tissue activator. This fact is particularly important for the clinical use of Tranexamic Acid, because it ensures an antihemorrhagic activity with an antifibrinolytic mechanism under a variety of conditions.
The acute toxicity of Tranexamic Acid is extremely low and chronic toxicity almost non-existent. Tranexamic Acid is well absorbed by oral route and the effect is already seen 15-30 minutes after administration. It is excreted mainly by renal route but more slowly than conventional hemostatics. These features make the Tranexamic Acid effect more lasting than those conventional hemostatics. Considerably lower single doses of Tranexamic Acid can thus be administered at greater intervals without the drug plasma levels dropping to inefficient levels of antifibrinolytic activity between one dose and the other.
Tranexamic Acid at therapeutic doses does not interfere with clotting processes and even a prolonged administration has not been seen to be accompanied by any tendency to thrombophilia.
Dosage & Administration
Adults-
The usual dose: 500-1000 mg 3 times daily.
For prophylaxis: The mean recommended daily doses are 0.5-1 gm orally, 500 mg by the parenteral (intravenous or intramuscular) route.
For therapy of hemorrhagic manifestations: the oral dose increases to 1-3 gm given in divided doses: in cases of particular seriousness and urgency, begin by injecting an ampoule (500 mg) slowly by intravenous route and administer the necessary subsequent oral doses.
Children-
For prophylaxis: For every kg of body weight from 5-10 mg are orally administered daily in divided doses.
For therapeutic purposes: The oral doses are doubled (from 10 to 20 mg/kg), while the intravenous and intramuscular treatment is begun with 10 mg/kg (=0.5 ml every 5 kg) by the slow intravenous route, continuing the oral administration up to the required dose. Where it is more convenient (e.g. in small babies) the ampoules, diluted in a little sweetened water, maybe orally administered instead of the Capsules.
Elderly patients: No reduction in dosage is necessary unless there is evidence of renal failure.
Interaction
Tranexamic Acid is a synthetic Amino Acid that is incompatible with solutions containing penicillins (eg: Benzyl penicillin). Thrombolytic drugs like Streptokinase & Urokinase antagonise the antifibrinolytic action of Tranexamic Acid. The potential for thrombus formation may be increased by concomitant administration of estrogen containing drugs, like oral contraceptives. Direct admixture of Tranexamic Acid with whole blood should be avoided during Transfusion.
Contraindications
Known individual hypersensitivity to the product. Thromboembolic disease, arterial and venous thrombosis, endocavitary hemorrhages, serious kidney failure.
Side Effects
Tranexamic Acid is generally well tolerated; there may be infrequent cases of sense of fatigue, conjunctival irritation, nasal blockage, itching, skin reddening, exanthems.
After oral administration there may be sign of nausea, diarrhea, gastric pyrosis.
There are rare cases of postural hypotension.
In the case of hypersensitivity to tranexamic acid, avoid or suspend treatment and start a suitable therapy.
Pregnancy & Lactation
Since the transplacental passage of the drug and its possible effects on the fetus are unknown, Tranexamic Acid should not be administered during known and presumed pregnancy. Tranexamic Acid passes into breast milk to a concentration of approximately one hundredth of the concentration in the maternal blood. An antifibrinolytic effect in the infant is unlikely.
Precautions & Warnings
Tranexamic Acid should be used in cases where there is hyperfibrinolysis. The prophylactic treatment must begin 24 hours before the operation and continue until 3-4 days after it.
The therapy of hemorrhages must be prolonged for at least 24 hours after manifestations have disappeared.
In hematuria, especially when this is not accompanied by any other hemorrhagic manifestations, reduce the doses to prevent formation of clots in the urinary tract.
Tranexamic Acid must not be used in serious renal insufficiency or anuric syndromes and must only be used with caution in less serious renal dysfunctions.
The administration of product requires particular care in cardiopathic and hepatopathic subjects.
Storage Conditions
Store in a dry place at 15-30°C, away from light and keep out of children's reach.
Alternative brands of Tranexamic Acid
Other brands with the same generic name, cheapest first.